{"id":384416,"date":"2020-11-18T16:08:23","date_gmt":"2020-11-18T21:08:23","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=384416"},"modified":"2020-11-18T16:08:23","modified_gmt":"2020-11-18T21:08:23","slug":"qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\/","title":{"rendered":"QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nQIAGEN and BioNTech to develop tissue-based <i>therascreen<\/i>\u00ae test covering a panel of HPV genotypes, paired with investigational treatment BNT113, to identify patients whose cancers are caused by HPV infections\n<\/li>\n<li>\nQIAGEN to pursue global regulatory approvals, including Premarket Approval from FDA for companion diagnostics\n<\/li>\n<li>\nCollaboration leverages QIAGEN\u00b4s global reach and market-leading position in companion diagnostics and HPV testing\n<\/li>\n<\/ul>\n<p>HILDEN, Germany &amp; GERMANTOWN, Md.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nQIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a strategic collaboration with BioNTech SE (Nasdaq: BNTX) to develop and commercialize a tissue-based companion diagnostic \u2013 to be used with investigational cancer treatment BNT113 \u2013 which identifies patients with squamous cell carcinoma of the head and neck (SCCHN) that are caused by specific infections by human papilloma virus (HPV).\n<\/p>\n<p>\nThe assay will detect the presence of HPV genotypes and will be developed on QIAGEN\u00b4s RGQ MDx platform, a member of the QIAsymphony family of products.\n<\/p>\n<p>\nQIAGEN plans to expand the panel for use across HPV-driven cancers such as cervical cancer and other cancers, in order to provide a universal HPV companion diagnostic (CDx) for QIAGEN\u2019s pharmaceutical partners.\n<\/p>\n<p>\nHead and neck squamous cell carcinoma is the sixth most common cancer. Every year, there are more than 650,000 cases leading to 330,000 deaths, according to a 2018 global cancer study. These numbers are expected to double by 2035, according to the World Health Organization. The incidence of HPV-related SCCHN has significantly increased in recent years.\n<\/p>\n<p>\nQIAGEN established the global HPV testing market over two decades ago. More than 100 million women have been tested for HPV infections using QIAGEN\u00b4s portfolio of HPV products, including hybrid capture, genotyping, and methylation tests.\n<\/p>\n<p>\nPlease find the full press release <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcorporate.qiagen.com%2Fnewsroom%2Fpress-releases%2F2020%2F20201118_qiagen_biontech_hpv&amp;esheet=52331305&amp;newsitemid=20201118005908&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=e613043296dabc6d9ccdd55775e1df4a\">here<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201118005908r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20201118005908\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201118005908\/en\/<\/a><\/span><\/p>\n<p><b>QIAGEN<br \/>\n<\/b><br \/><b>Investor Relations<br \/>\n<\/b><br \/>John Gilardi<br \/>\n<br \/>+49 2103 29 11711\n<\/p>\n<p>\nPhoebe Loh<br \/>\n<br \/>+49 2103 29 11457<br \/>\n<br \/>e-mail: <a rel=\"nofollow\" href=\"mailto:ir@QIAGEN.com\">ir@QIAGEN.com<\/a><\/p>\n<p><b>Public Relations<br \/>\n<\/b><br \/>Thomas Theuringer<br \/>\n<br \/>+49 2103 29 11826\n<\/p>\n<p>\nRobert Reitze<br \/>\n<br \/>+49 2103 29 11676<br \/>\n<br \/>e-mail: <a rel=\"nofollow\" href=\"mailto:pr@QIAGEN.com\">pr@QIAGEN.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Switzerland United States Austria North America Europe Germany Maryland<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Science Other Science Biotechnology Research Pharmaceutical Oncology Health Medical Devices<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck QIAGEN and BioNTech to develop tissue-based therascreen\u00ae test covering a panel of HPV genotypes, paired with investigational treatment BNT113, to identify patients whose cancers are caused by HPV infections QIAGEN to pursue global regulatory approvals, including Premarket Approval from FDA for companion diagnostics Collaboration leverages QIAGEN\u00b4s global reach and market-leading position in companion diagnostics and HPV testing HILDEN, Germany &amp; GERMANTOWN, Md.&#8211;(BUSINESS WIRE)&#8211; QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a strategic collaboration with BioNTech SE (Nasdaq: BNTX) to develop and commercialize a tissue-based companion diagnostic \u2013 to be used with investigational cancer treatment BNT113 \u2013 which identifies patients &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-384416","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck QIAGEN and BioNTech to develop tissue-based therascreen\u00ae test covering a panel of HPV genotypes, paired with investigational treatment BNT113, to identify patients whose cancers are caused by HPV infections QIAGEN to pursue global regulatory approvals, including Premarket Approval from FDA for companion diagnostics Collaboration leverages QIAGEN\u00b4s global reach and market-leading position in companion diagnostics and HPV testing HILDEN, Germany &amp; GERMANTOWN, Md.&#8211;(BUSINESS WIRE)&#8211; QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a strategic collaboration with BioNTech SE (Nasdaq: BNTX) to develop and commercialize a tissue-based companion diagnostic \u2013 to be used with investigational cancer treatment BNT113 \u2013 which identifies patients &hellip; Continue reading &quot;QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-18T21:08:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201118005908r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck\",\"datePublished\":\"2020-11-18T21:08:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\\\/\"},\"wordCount\":373,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201118005908r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\\\/\",\"name\":\"QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201118005908r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2020-11-18T21:08:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201118005908r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201118005908r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\/","og_locale":"en_US","og_type":"article","og_title":"QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck - Market Newsdesk","og_description":"QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck QIAGEN and BioNTech to develop tissue-based therascreen\u00ae test covering a panel of HPV genotypes, paired with investigational treatment BNT113, to identify patients whose cancers are caused by HPV infections QIAGEN to pursue global regulatory approvals, including Premarket Approval from FDA for companion diagnostics Collaboration leverages QIAGEN\u00b4s global reach and market-leading position in companion diagnostics and HPV testing HILDEN, Germany &amp; GERMANTOWN, Md.&#8211;(BUSINESS WIRE)&#8211; QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a strategic collaboration with BioNTech SE (Nasdaq: BNTX) to develop and commercialize a tissue-based companion diagnostic \u2013 to be used with investigational cancer treatment BNT113 \u2013 which identifies patients &hellip; Continue reading \"QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-18T21:08:23+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201118005908r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck","datePublished":"2020-11-18T21:08:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\/"},"wordCount":373,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201118005908r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\/","name":"QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201118005908r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2020-11-18T21:08:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201118005908r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201118005908r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/384416","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=384416"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/384416\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=384416"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=384416"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=384416"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}